It refers to compounds extracted from formula (I), where x is n or CH； R1 is a formula (I),Page: 1R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16 and R17 are all h or methyl； R25 or cr26r27 is O, ch25 or cr26r27, where R25 is hydroxy or alcoxyl (C1-C3)；R26 and R27 are h and halogen respectively - 3-methyl-morfolin-4-4-4-4-il-4-1) - 4-1) - 2-1) - 2-5 -------- among others. He also mentioned a pharmaceutical composer These compounds have phospho-3-quinase (PI3K) and MTR inhibitory activities, which can be used to treat cancer or neurodegenerative disorders.SE REFIERE A COMPUESTOS DERIVADOS DE PURINA DE FORMULA (I) DONDE X ES N O CH； R1 ES UN COMPUESTO DE FORMULA (i), (ii), ENTRE OTROS； R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16 Y R17 SON CADA UNO H O METILO； Y ES O, CHR25 O CR26R27, EN DONDE R25 ES HIDROXILO O ALCOXILO(C1-C3)； R26 Y R27 SON CADA UNO H O HALOGENO. SON COMPUESTOS PREFERIDOS: 3-(2,4-DIMORFOLINO-7H-PIRROLO[2,3-d]PIRIMIDIN-6-IL)FENOL； 2,6-BIS-((S)-3-METIL-MORFOLIN-4-IL)-8-(1H-PIRROLO[2,3-b]PIRIDINA-4-IL)-9H-PURINA； {2-FLUORO-5-[6-((S)-3-METIL-MORFOLIN-4-IL)-2-MORFOLIN-4-IL-9H-PURIN-8-IL]-FENIL}-METANOL； ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD INHIBITORIA DE LA FOSFATIDILINOSITOL-3-QUINASA (PI3K) Y mTOR SIENDO UTILES EN EL TRATAMIENTO DE CANCER O UN TRASTORNO NEURODEGENERATIVO
